CEVA Logistics transport oxygen concentrators to Indonesia
CEVA Logistics announces the transport of oxygen concentrators from the U.S. to Indonesia via Singapore. In total, 1,380 machines are being donated by the Changi Foundation together with more than 30 other airport partners, as well as individual airport employees.
CEVA Logistics continues supporting Indonesia with the fight against the COVID-19 virus. It announces the transport of oxygen concentrators from the U.S. to Indonesia via Singapore. As part of the broader Singapore Changi Airport community, CEVA is participating in the aid project organized by the Changi Airport Group.
The project’s first shipment of oxygen concentrators from Los Angeles weighed more than 14,000 kilograms and was delivered directly to the CEVA Logistics warehouse located within the Airport Logistics Park of Singapore.
With many Southeast Asian and Pacific countries affected by the highly transmissible Delta variant, CEVA Logistics is using its global network to connect the right medical supplies with those that need them. In total, 1,380 machines are being donated by the Changi Foundation together with more than 30 other airport partners, as well as individual airport employees.
Says Elaine Low, managing director for Southeast Asia and Pacific, CEVA Logistics, ‘‘At CEVA Logistics, we believe our global presence gives us a great responsibility in the communities in which our employees live and work. We want to support and enrich these local communities through what we do best: logistics and transportation services. We are honored to partner with Changi Airport Group in this humanitarian effort for our friends in Indonesia. We hope that these medical supplies will bring much-needed relief to those who are battling COVID-19, and we wish them a speedy recovery.’’
Early in the pandemic, the company organized an airlift of two flights per week to deliver several hundred million masks from China to France over the course of months. In addition, CEVA was also appointed by General Motors (GM) in April 2020 to manage its entire ventilator production supply chain in support of the U.S. pandemic response.